🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several professionals said the demand for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the platform has removed violative material and banned related hashtags and query recommendations. The company said it was committed to maintaining the platform safe and investing in strengthening compliance measures.

Online Trading Activities

Research also discovered groups with up to 9,000 members selling retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, positive reviews and step-by-step guides for mixing or administering at home.

After moments of entering one community, a vendor shared WhatsApp details, where most purchases occur. The seller sent an guidebook and promised delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or previous experience.

Product Information and Costs

Within these groups, posts display dark colored parcels with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it actively monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they can’t verify. Even if the research behind this drug is valid, these digital products may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to potentially serious health risks”.